Bevacizumab Supplier-Buyer Network — Trade Flow Analysis

Name: Bevacizumab Supplier-Buyer Trade Network Dataset — 196+ Indian Exporters, 19+ Importers, 100+ Countries (DGFT 2022–2026)
Creator: TransData Nexus
License: https://transdatanexus.com/terms
Keywords: Bevacizumab supplier network, Bevacizumab buyers, pharmaceutical export India, Bevacizumab trade data

TransData Nexus

Bevacizumab

India Pharmaceutical Trade Intelligence

$46.9M196 Suppliers100 CountriesHS 30021500

ExportsIndia → RUSSIA50.3%India → NETHERLANDS14.3%

ImportsSWITZERLAND → India$1.2B GERMANY → India$344.1M

#1 Buyer: JSC R-PHARM

Who Supplies Bevacizumab? Top Manufacturers & Buyers 2026 — DR.REDDY'S LABORATORIES LTD Leads | TransData Nexus | TransData Nexus

1DR.REDDY'S LABORATORIES LTD

DR.REDDY'S LABORATORIES LTD is the first-largest Bevacizumab exporter from India, with a market share of 24.5% and a total export value of $11.5M across 131 shipments. Their average shipment value of $87.6K is above the market average of $33.3K, suggesting premium or bulk contract pricing.

DR.REDDY'S LABORATORIES LTD serves 5 named buyers in our database. JSC R-PHARM is the dominant customer, accounting for 84.0% of this supplier's tracked business. Top customers include:

• JSC R-PHARM — $9.6M across 110 shipments (84.0% of this supplier's total exports)

• DR.REDDYS LABORATORIES SAS — $833.4K across 10 shipments (7.3% of this supplier's total exports)

• DR.REDDYS LABORATORIES SAS — $492.4K across 6 shipments (4.3% of this supplier's total exports)

• NA — $338.0K across 4 shipments (2.9% of this supplier's total exports)

• STATE TRADING ORGANIZATION PLC — $169.0K across 2 shipments (1.5% of this supplier's total exports)

Key Insight: DR.REDDY'S LABORATORIES LTD's per-shipment value of $87.6K is 163% above the market average of $33.3K, consistent with large-order contracts or value-added formulations.

2BIOCON BIOLOGICS INDIA LIMITED

BIOCON BIOLOGICS INDIA LIMITED is the second-largest Bevacizumab exporter from India, with a market share of 18.3% and a total export value of $8.6M across 46 shipments. Their average shipment value of $186.6K is above the market average of $33.3K, suggesting premium or bulk contract pricing.

BIOCON BIOLOGICS INDIA LIMITED serves 5 named buyers in our database. BIOCON BIOLOGICS UK LIMITED is the dominant customer, accounting for 57.2% of this supplier's tracked business. Top customers include:

• BIOCON BIOLOGICS UK LIMITED — $4.9M across 26 shipments (57.2% of this supplier's total exports)

• XXOCOXXBIOXXGICXXUK XXMITXX — $3.0M across 16 shipments (34.6% of this supplier's total exports)

• XXOSWXXS PXXRMAXXUTI — $419.0K across 2 shipments (4.9% of this supplier's total exports)

• XXOSIXXLARXXOLLXXORAXXONSXXRELXXD LXXITEX — $202.1K across 1 shipments (2.4% of this supplier's total exports)

• XXOSIXXLARXXNEWXX LI — $88.3K across 0 shipments (1.0% of this supplier's total exports)

Key Insight: BIOCON BIOLOGICS INDIA LIMITED's per-shipment value of $186.6K is 460% above the market average of $33.3K, consistent with large-order contracts or value-added formulations.

3DR REDDY S LABORATORIES LTD

DR REDDY S LABORATORIES LTD is the third-largest Bevacizumab exporter from India, with a market share of 9.9% and a total export value of $4.6M across 14 shipments. Their average shipment value of $331.8K is above the market average of $33.3K, suggesting premium or bulk contract pricing.

DR REDDY S LABORATORIES LTD serves 1 named buyer in our database. JSC R-PHARM is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:

• JSC R-PHARM — $4.6M across 14 shipments (100.0% of this supplier's total exports)

Key Insight: DR REDDY S LABORATORIES LTD's per-shipment value of $331.8K is 896% above the market average of $33.3K, consistent with large-order contracts or value-added formulations.

4RELIANCE LIFE SCIENCES PRIVATE LIMITED

RELIANCE LIFE SCIENCES PRIVATE LIMITED is the fourth-largest Bevacizumab exporter from India, with a market share of 4.0% and a total export value of $1.9M across 73 shipments. Their average shipment value of $25.8K is below the market average of $33.3K, reflecting a high-volume, competitive pricing strategy.

RELIANCE LIFE SCIENCES PRIVATE LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• SEAN DOMINICAN SRL — $762.5K across 30 shipments (40.5% of this supplier's total exports)

• WELL AND TECH MEDICAL LTD. — $525.5K across 20 shipments (27.9% of this supplier's total exports)

• LEVANT PULSE — $339.2K across 13 shipments (18.0% of this supplier's total exports)

• PHARMACHEM PRIVATE L — $150.3K across 6 shipments (8.0% of this supplier's total exports)

• OCTELLE CO., LTD — $105.2K across 4 shipments (5.6% of this supplier's total exports)

Key Insight: RELIANCE LIFE SCIENCES PRIVATE LIMITED operates with high shipment frequency (73 shipments) at a per-shipment value of $25.8K, indicating a broad distribution network with many smaller, regular orders.

5ZYDUS LIFESCIENCES LIMITED

ZYDUS LIFESCIENCES LIMITED is the fifth-largest Bevacizumab exporter from India, with a market share of 3.8% and a total export value of $1.8M across 21 shipments. Their average shipment value of $85.0K is above the market average of $33.3K, suggesting premium or bulk contract pricing.

ZYDUS LIFESCIENCES LIMITED serves 5 named buyers in our database. ZYDUS PHARMACEUTICALS M?XICO S.A. D is the dominant customer, accounting for 92.9% of this supplier's tracked business. Top customers include:

• ZYDUS PHARMACEUTICALS M?XICO S.A. D — $1.7M across 20 shipments (92.9% of this supplier's total exports)

• FARMEDICAL S.R.L. — $83.5K across 1 shipments (4.7% of this supplier's total exports)

• D. K. M. PHARMACEUTI — $19.8K across 0 shipments (1.1% of this supplier's total exports)

• RIPPLE PHARMACEUTICA — $14.1K across 0 shipments (0.8% of this supplier's total exports)

• RIPPLE PHARMACEUTICA — $9.6K across 0 shipments (0.5% of this supplier's total exports)

Key Insight: ZYDUS LIFESCIENCES LIMITED's per-shipment value of $85.0K is 155% above the market average of $33.3K, consistent with large-order contracts or value-added formulations.

6DR REDDYS LABORATORIES LIMITED

DR REDDYS LABORATORIES LIMITED is the fifth-largest Bevacizumab exporter from India, with a market share of 2.5% and a total export value of $1.2M across 10 shipments. Their average shipment value of $117.5K is above the market average of $33.3K, suggesting premium or bulk contract pricing.

DR REDDYS LABORATORIES LIMITED serves 5 named buyers in our database. DR.REDDYS LABORATORIES SAS is the dominant customer, accounting for 72.7% of this supplier's tracked business. Top customers include:

• DR.REDDYS LABORATORIES SAS — $853.9K across 7 shipments (72.7% of this supplier's total exports)

• DR.REDDYS LABORATORIES SAS — $110.3K across 1 shipments (9.4% of this supplier's total exports)

• DR REDDYS LABORATORI — $105.5K across 1 shipments (9.0% of this supplier's total exports)

• STATE TRADING ORGANIZATION PLC — $93.3K across 1 shipments (7.9% of this supplier's total exports)

• HYPERPHARM LTD — $11.8K across 0 shipments (1.0% of this supplier's total exports)

Key Insight: DR REDDYS LABORATORIES LIMITED's per-shipment value of $117.5K is 253% above the market average of $33.3K, consistent with large-order contracts or value-added formulations.

1Russia

Russia ranks as the first-largest destination for Bevacizumab imports from India, with a total trade value of $23.6M across 66 shipments — representing a 50.3% share of all Bevacizumab exports. The average shipment value of $357.6K is above the global average of $33.3K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.

Named Bevacizumab importers in Russia: JSC R-PHARM is the largest buyer, accounting for 79.1% ($18.7M) of this market's total imports.

• JSC R-PHARM — $18.7M (79.1% of Russia's total)

• JSC R PHARM — $4.9M (20.8% of Russia's total)

Key Insight: Russia's per-shipment average of $357.6K (973% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Russia is a key market for Bevacizumab imports from India.

Primary Market

Secondary Market

2Netherlands

Netherlands ranks as the second-largest destination for Bevacizumab imports from India, with a total trade value of $6.7M across 20 shipments — representing a 14.3% share of all Bevacizumab exports. The average shipment value of $336.5K is above the global average of $33.3K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.

Named Bevacizumab importers in Netherlands: BIOCON BIOLOGICS UK LIMITED is the largest buyer, accounting for 72.9% ($4.9M) of this market's total imports.

• BIOCON BIOLOGICS UK LIMITED — $4.9M (72.9% of Netherlands's total)

• XXOSIXXLARXXOLLXXORAXXONSXXRELXXD LXXITEX — $202.1K (3.0% of Netherlands's total)

Key Insight: Netherlands's per-shipment average of $336.5K (910% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Netherlands is a key market for Bevacizumab imports from India.

Primary Market

Secondary Market

3Colombia

Colombia ranks as the third-largest destination for Bevacizumab imports from India, with a total trade value of $3.7M across 32 shipments — representing a 7.9% share of all Bevacizumab exports. The average shipment value of $116.2K is above the global average of $33.3K, indicating high-value procurement contracts or branded formulations. This market is served by 3 tracked buyers.

Named Bevacizumab importers in Colombia: DR.REDDYS LABORATORIES SAS is the largest buyer, accounting for 51.0% ($1.9M) of this market's total imports.

• DR.REDDYS LABORATORIES SAS — $1.9M (51.0% of Colombia's total)

• DRREDDYS LABORATORIES SAS — $853.9K (23.0% of Colombia's total)

• DR. REDDYS LABORATORIES SAS — $777.6K (20.9% of Colombia's total)

Key Insight: Colombia's per-shipment average of $116.2K (249% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Colombia is a key market for Bevacizumab imports from India.

Primary Market

Secondary Market

4Mexico

Mexico ranks as the fourth-largest destination for Bevacizumab imports from India, with a total trade value of $1.7M across 3 shipments — representing a 3.6% share of all Bevacizumab exports. The average shipment value of $562.3K is above the global average of $33.3K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.

Named Bevacizumab importers in Mexico: ZYDUS PHARMACEUTICALS M?XICO S.A. D is the largest buyer, accounting for 98.3% ($1.7M) of this market's total imports.

• ZYDUS PHARMACEUTICALS M?XICO S.A. D — $1.7M (98.3% of Mexico's total)

Key Insight: Mexico's per-shipment average of $562.3K (1588% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Mexico is a key market for Bevacizumab imports from India.

Primary Market

Secondary Market

5Venezuela

Venezuela ranks as the fifth-largest destination for Bevacizumab imports from India, with a total trade value of $1.4M across 2 shipments — representing a 3.1% share of all Bevacizumab exports. The average shipment value of $721.3K is above the global average of $33.3K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.

Named Bevacizumab importers in Venezuela: WELL AND TECH MEDICAL LTD. is the largest buyer, accounting for 36.4% ($525.5K) of this market's total imports.

• WELL AND TECH MEDICAL LTD. — $525.5K (36.4% of Venezuela's total)

Key Insight: Venezuela's per-shipment average of $721.3K (2065% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Venezuela is a key market for Bevacizumab imports from India.

Primary Market

Secondary Market

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Bevacizumab.
2.Flow Mapping: 196 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
3.Value Aggregation: Trade value per supplier-buyer link aggregated from 1,408 individual shipment records. Values are FOB in USD.
4.Geographic Clustering: Buyer networks clustered across 100 destination countries to identify geographic concentration patterns.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

1,408 Verified Shipments

196 manufacturers in network

Expert-Reviewed

By pharmaceutical trade specialists

Bevacizumab

Bevacizumab

Who Supplies Bevacizumab? Top Manufacturers & Their Global Buyers

🏭 Market Analysis: Top Suppliers & Customer Networks

Market Intelligence

Official References & Regulatory Resources

Who Supplies Bevacizumab? Top Manufacturers & Their Buyers

Supplier-Customer Network Analysis

Bevacizumab Supplier Network — Key Market Intelligence

Market Analysis: Top Suppliers & Their Customer Networks

1DR.REDDY'S LABORATORIES LTD

2BIOCON BIOLOGICS INDIA LIMITED

3DR REDDY S LABORATORIES LTD

4RELIANCE LIFE SCIENCES PRIVATE LIMITED

5ZYDUS LIFESCIENCES LIMITED

6DR REDDYS LABORATORIES LIMITED

From Indian Factories to Global Pharmacies — How Bevacizumab Flows

🌍 Market Analysis: Top Importing Countries & Importers

Where Does Bevacizumab Go? Top Importing Countries & Their Buyers

Geographic Market Flow Analysis

Market Analysis: Top Importing Countries & Their Importers

1Russia

2Netherlands

3Colombia

4Mexico

5Venezuela

People Also Ask — Bevacizumab Supplier & Trade Network

Bevacizumab Trade Network — Key Takeaways

Network Overview

Supplier Network

Country Network

Network Insights

Related Analysis

Network Intelligence

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology